BioNTech Boss Uğur Şahin is Much More Optimistic About Vaccines Against the Omikron Variant

While Moderna boss Stephane Bancel had open doubts about the effectiveness of the current mRNA vaccines against the Omikron variant, BioNTech boss Uğur Şahin is much more optimistic. BioNTech boss UĞur Şahin expects the existing Covid-19 vaccine from Mainz Manufacturer and its partner Pfizer can also protect the new Omikron variant from serious disease. After all, Omikron is not the first Corona variant that has emerged, said Sahin yesterday evening in Mainz before a prize was awarded to him and his wife Özlem Türeci.

It depends on the third vaccination “We think it is likely that those who have been vaccinated will have significant protection against serious illnesses caused by Omikron,” Sahin told  media. “We assume that this protection is even more pronounced when the people have received their third vaccination.” Sahin had previously made a similar statement in the “Wall Street Journal”: Nobody should lose their nerve because of Omicron. give everyone booster

Panic sales according to Moderna statements The almost relaxed statements of the BioNTech boss stand in clear contrast to the most recent statements by Stéphane Bancel. The head of the US pharmaceutical company Moderna yesterday alarmed the global stock markets with skeptical remarks and triggered panic selling. Investors feared that Omikron could again threaten massive restrictions on economic life. The DAX lost 1.2 percent to 15,100 points. Cancel had told the Financial Times that because of the many mutations in the Omikron variant, scientists assumed a “considerable decrease” in the protective effect. “I think it’s going to be a significant drop. I just don’t know how much because we’re going to have to wait for the data. But all the scientists I’ve spoken to are of the opinion, ‘This is not going to be good’.”